Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Hydreight Technologies Inc ( (TSE:NURS) ) just unveiled an announcement.
Hydreight Technologies Inc. reported a 33% year-over-year revenue growth for the first half of 2025 and achieved its third consecutive quarter of profitability. The company has focused on making its VSDHOne platform modular and has invested in strategic acquisitions to strengthen margins and accelerate growth. The company also launched a personalized genetic testing and wellness solution, expanded into new health verticals, and signed a strategic partnership with Perfect Scripts, LLC. These efforts position Hydreight to scale efficiently and achieve its 2025 objectives.
The most recent analyst rating on (TSE:NURS) stock is a Buy with a C$8.00 price target. To see the full list of analyst forecasts on Hydreight Technologies Inc stock, see the TSE:NURS Stock Forecast page.
More about Hydreight Technologies Inc
Hydreight Technologies Inc. operates as a mobile clinical network and medical platform, offering flexible at-home medical services across the United States. The company focuses on providing a modular platform, VSDHOne, which allows customers to adopt services tailored to their needs. Hydreight is involved in strategic investments and acquisitions to enhance its market presence and expand its service ecosystem.
Average Trading Volume: 337,843
Technical Sentiment Signal: Buy
Current Market Cap: C$80.28M
For detailed information about NURS stock, go to TipRanks’ Stock Analysis page.